Research Article
Comparable Enhanced Prothrombogenesis in Simple Central Obesity and Metabolic Syndrome
Table 3
Association between obesity categories of subjects with quartiles of fibrinolysis biomarkers.
| | Biomarkers | MS n (%) | COB n (%) | NC n (%) | value |
| | tPA (ng/ml) | | | | | | Q1: <2.66 | 53 (24.9) | 77 (42.3) | 52 (53.6) | <0.001 | | Q2: 2.66–4.41 | 54 (25.4) | 50 (27.5) | 29 (29.9) | | Q3: 4.42–7.19 | 54 (25.4) | 33 (18.1) | 12 (12.4) | | Q4: > 7.19 | 52 (24.4) | 22 (12.1) | 4 (4.1) |
| | PAI-1 (ng/ml) | | | | | | Q1: <27.80 | 41 (20.8) | 38 (25.2) | 33 (39.3) | <0.01 | | Q2: 27.80–45.09 | 52 (26.4) | 40 (26.5) | 20 (23.8) | | Q3: 45.10–76.83 | 50 (25.4) | 42 (27.8) | 20 (23.8) | | Q4: >76.83 | 54 (27.4) | 31 (20.5) | 11 (13.1) |
|
|
MS: metabolic syndrome; COB: simple central obesity; NC: normal controls; tPA: tissue plasminogen activator; PAI-1: plasminogen activator inhibitor.
|
